Dioxoisoquinoline-4-carboxanilides, novel nonsteroidal anti-inflammatory agents with a species-specific effect on basal metabolism.
D000510:Alpha-Globulins / Q000378:metabolism; D000813:Anilides / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D001481:Basal Metabolism / Q000187:drug effects*; D004140:Dinitrophenols / Q000494:pharmacology; D004285:Dogs; D004586:Electrophoresis; D005260:Female; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D007456:Iodine Isotopes; D007546:Isoquinolines / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D010653:Phenylbutazone / Q000097:blood / Q000378:metabolism; D011485:Protein Binding; D051381:Rats; D013045:Species Specificity; D013974:Thyroxine / Q000378:metabolism; D014528:Uricosuric Agents / Q000494:pharmacology
D000510:Alpha-Globulins; D000813:Anilides; D000893:Anti-Inflammatory Agents; D004140:Dinitrophenols; D007456:Iodine Isotopes; D007546:Isoquinolines; D014528:Uricosuric Agents; D010653:Phenylbutazone; D013974:Thyroxine